Hannah Goetz was 17 when she had a double lung transplant. Her tacrolimus medication was supposed to help her body accept her ...

SaveHealth reports that insulin therapy is crucial for diabetes management, with various options available, including rapid- ...

Abbreviated new drug application filings have declined to 600 in the financial year 2025 (ending in September) versus 740 in ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Want to stay on top of ...

Tracy Beth Høeg, MD, PhD, was named acting director of the FDA’s Center for Drug Evaluation and Research, effective Dec. 3. She succeeds Richard Pazdur, MD, who was appointed director of the CDER on ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The company is getting new ...

PHOENIX — With flu cases rising overseas in countries like the United Kingdom and a new variant identified in Japan, experts warn that the United States could face an earlier flu season this year.

Pazdur, a 26-year veteran of the FDA, will take over as the director of the Center for Drug Evaluation and Research (CDER), the FDA’s largest unit. A cancer specialist, Pazdur has previously held ...

Dr. Richard Pazdur, who has been the F.D.A.’s top cancer drug regulator, represents a stabilizing choice for an agency reeling under staff cuts and low morale. By Christina Jewett and Rebecca Robbins ...

Members of the editorial and news staff of the Los Angeles magazine and the Engine Vision Media Network were not involved in the creation of this content. A new agreement between Biocon Biologics Ltd.

The U.S. Food and Drug Administration (FDA) announced Wednesday that it will relax certain rules for approving low-cost versions of some high-priced medications, in an effort to speed up access to ...